Lim Soeyantho

Coo/deputy President Director - BOD Member at COMBIPHAR

Lim Soeyantho is an accomplished executive with extensive experience in various leadership roles across multiple industries. Currently serving as COO and Deputy President Director at COMBIPHAR since September 2011, Lim also holds positions as President Director at Air Mancur Group and PT Simba Indosnack Makmur. Previous experience includes Managing Director at Landson - Mensa Group and Regional Manager for SE Asia and Oceania at Frigoglass, where responsibilities encompassed business development, sales, and operational management. A background in finance is highlighted by roles as Finance Director at GlaxoSmithKline and Audit Supervisor at Pricewaterhouse Coopers. Lim holds a Bachelor's degree in Economics/Accountancy from the University of Trisakti.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


COMBIPHAR

1 followers

Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.